Posts

Exclusive: Sri Lanka halts imports of Johnson & Johnson Baby Powder pending asbestos tests

Image
Sri Lanka has halted imports of Johnson & Johnson Baby Powder until the company proves its product is free from cancer-causing asbestos, two government officials and the product's local distributor told Reuters. from Reuters: Health News https://reut.rs/2FZyhwL

E-cigarettes help more smokers quit than patches and gum, study finds

Image
E-cigarettes are almost twice as effective at helping smokers quit as nicotine replacement treatments like patches, lozenges and gum, according to the results of a major clinical trial. from Reuters: Health News https://reut.rs/2CRXbuo

Other factors may explain preterm births associated with IVF

Image
(Reuters Health) - Women are more likely to have preemies when they use reproductive technologies like in vitro fertilization (IVF), but a new study comparing outcomes for these babies to siblings conceived naturally suggests that other factors may be the cause of these early arrivals. from Reuters: Health News https://reut.rs/2FW7yS1

Aerobic exercise may improve thinking skills in adults of all ages

Image
(Reuters Health) - Numerous studies have shown that aerobic exercise can improve cognition in seniors, but a small new study finds that vigorous workouts boost thinking skills in younger adults as well. from Reuters: Health News https://reut.rs/2BcwcK9

Kidney function worsens as people get more obese

Image
(Reuters Health) - With or without existing kidney disease, kidney function is more likely to decline over time the more severely obese a person is, a large study suggests. from Reuters: Health News https://reut.rs/2RXxeUA

FDA approves Mylan's generic of Advair asthma treatment

Image
The U.S. Food and Drug Administration (FDA) approved Mylan NV's generic version of GlaxoSmithKline-developed blockbuster asthma treatment Advair, driving shares of Mylan 7 percent higher on Wednesday. from Reuters: Health News https://reut.rs/2SfFFd3

U.S. lawmakers request info from insulin makers on rising prices

Image
Two powerful U.S. lawmakers sent letters to the three leading insulin manufacturers on Wednesday requesting information on why its cost has skyrocketed in recent years and how much the companies profit from the life-sustaining diabetes treatment. from Reuters: Health News https://reut.rs/2FYXZ4y